nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CYP2C9—brain cancer	0.488	1	CbGaD
Celecoxib—CYP2D6—Lomustine—brain cancer	0.048	0.246	CbGbCtD
Celecoxib—PTGS2—Etoposide—brain cancer	0.0373	0.191	CbGbCtD
Celecoxib—CYP2D6—Hydroxyurea—brain cancer	0.0364	0.186	CbGbCtD
Celecoxib—CYP3A4—Temozolomide—brain cancer	0.0359	0.184	CbGbCtD
Celecoxib—CYP3A4—Lomustine—brain cancer	0.0305	0.156	CbGbCtD
Celecoxib—CYP3A4—Etoposide—brain cancer	0.00737	0.0377	CbGbCtD
Celecoxib—Etoricoxib—CYP2C9—brain cancer	0.0027	0.634	CrCbGaD
Celecoxib—MAPK14—blood vessel—brain cancer	0.00244	0.0393	CbGeAlD
Celecoxib—MAPK14—hindbrain—brain cancer	0.00232	0.0375	CbGeAlD
Celecoxib—PDPK1—gonad—brain cancer	0.00184	0.0298	CbGeAlD
Celecoxib—PDPK1—pituitary gland—brain cancer	0.0018	0.029	CbGeAlD
Celecoxib—PDPK1—medulla oblongata—brain cancer	0.00174	0.028	CbGeAlD
Celecoxib—PDPK1—midbrain—brain cancer	0.00159	0.0256	CbGeAlD
Celecoxib—Sulfaphenazole—CYP2C9—brain cancer	0.00156	0.366	CrCbGaD
Celecoxib—PDPK1—spinal cord—brain cancer	0.00155	0.025	CbGeAlD
Celecoxib—CA4—ganglion—brain cancer	0.00144	0.0232	CbGeAlD
Celecoxib—PDPK1—endocrine gland—brain cancer	0.00139	0.0225	CbGeAlD
Celecoxib—PDPK1—head—brain cancer	0.00138	0.0222	CbGeAlD
Celecoxib—MAPK14—brainstem—brain cancer	0.00133	0.0215	CbGeAlD
Celecoxib—CA5A—endocrine gland—brain cancer	0.00131	0.0211	CbGeAlD
Celecoxib—PDPK1—central nervous system—brain cancer	0.00126	0.0203	CbGeAlD
Celecoxib—PDPK1—cerebellum—brain cancer	0.00123	0.0198	CbGeAlD
Celecoxib—MAPK14—telencephalon—brain cancer	0.00118	0.0191	CbGeAlD
Celecoxib—CA14—telencephalon—brain cancer	0.00115	0.0185	CbGeAlD
Celecoxib—CA4—hindbrain—brain cancer	0.00109	0.0176	CbGeAlD
Celecoxib—PDPK1—brain—brain cancer	0.000997	0.0161	CbGeAlD
Celecoxib—MAPK14—pituitary gland—brain cancer	0.000963	0.0155	CbGeAlD
Celecoxib—CA2—hindbrain—brain cancer	0.000905	0.0146	CbGeAlD
Celecoxib—CA14—medulla oblongata—brain cancer	0.000904	0.0146	CbGeAlD
Celecoxib—CA12—telencephalon—brain cancer	0.000897	0.0145	CbGeAlD
Celecoxib—CA6—head—brain cancer	0.000833	0.0134	CbGeAlD
Celecoxib—MAPK14—spinal cord—brain cancer	0.000828	0.0134	CbGeAlD
Celecoxib—CA14—midbrain—brain cancer	0.000826	0.0133	CbGeAlD
Celecoxib—CA14—spinal cord—brain cancer	0.000806	0.013	CbGeAlD
Celecoxib—CA9—endocrine gland—brain cancer	0.000765	0.0123	CbGeAlD
Celecoxib—PTGS2—endothelium—brain cancer	0.00076	0.0123	CbGeAlD
Celecoxib—MAPK14—endocrine gland—brain cancer	0.000746	0.012	CbGeAlD
Celecoxib—MAPK14—head—brain cancer	0.000736	0.0119	CbGeAlD
Celecoxib—PTGS2—blood vessel—brain cancer	0.000701	0.0113	CbGeAlD
Celecoxib—CA9—cerebellum—brain cancer	0.000674	0.0109	CbGeAlD
Celecoxib—MAPK14—central nervous system—brain cancer	0.000672	0.0108	CbGeAlD
Celecoxib—CA5B—gonad—brain cancer	0.000671	0.0108	CbGeAlD
Celecoxib—MAPK14—cerebellum—brain cancer	0.000657	0.0106	CbGeAlD
Celecoxib—CA14—cerebellum—brain cancer	0.000639	0.0103	CbGeAlD
Celecoxib—CA4—brainstem—brain cancer	0.000626	0.0101	CbGeAlD
Celecoxib—CYP2D6—hindbrain—brain cancer	0.000575	0.00927	CbGeAlD
Celecoxib—CA12—endocrine gland—brain cancer	0.000566	0.00912	CbGeAlD
Celecoxib—CA12—head—brain cancer	0.000558	0.00901	CbGeAlD
Celecoxib—CA4—telencephalon—brain cancer	0.000555	0.00896	CbGeAlD
Celecoxib—MAPK14—brain—brain cancer	0.000533	0.0086	CbGeAlD
Celecoxib—CA14—brain—brain cancer	0.000519	0.00837	CbGeAlD
Celecoxib—CA2—brainstem—brain cancer	0.000519	0.00837	CbGeAlD
Celecoxib—CA12—central nervous system—brain cancer	0.00051	0.00822	CbGeAlD
Celecoxib—CA5B—endocrine gland—brain cancer	0.000507	0.00819	CbGeAlD
Celecoxib—CA5B—head—brain cancer	0.000501	0.00808	CbGeAlD
Celecoxib—ORM1—spinal cord—brain cancer	0.000499	0.00804	CbGeAlD
Celecoxib—CA2—telencephalon—brain cancer	0.00046	0.00743	CbGeAlD
Celecoxib—CA5B—central nervous system—brain cancer	0.000457	0.00738	CbGeAlD
Celecoxib—CA4—pituitary gland—brain cancer	0.000452	0.00729	CbGeAlD
Celecoxib—ORM1—endocrine gland—brain cancer	0.000449	0.00724	CbGeAlD
Celecoxib—CA4—medulla oblongata—brain cancer	0.000436	0.00704	CbGeAlD
Celecoxib—CA12—brain—brain cancer	0.000405	0.00653	CbGeAlD
Celecoxib—ORM1—central nervous system—brain cancer	0.000405	0.00653	CbGeAlD
Celecoxib—CA4—midbrain—brain cancer	0.000399	0.00643	CbGeAlD
Celecoxib—CA4—spinal cord—brain cancer	0.000389	0.00628	CbGeAlD
Celecoxib—ABCC4—endocrine gland—brain cancer	0.000381	0.00615	CbGeAlD
Celecoxib—ABCC4—head—brain cancer	0.000376	0.00607	CbGeAlD
Celecoxib—CA2—pituitary gland—brain cancer	0.000375	0.00605	CbGeAlD
Celecoxib—CA5B—brain—brain cancer	0.000363	0.00586	CbGeAlD
Celecoxib—CA2—medulla oblongata—brain cancer	0.000362	0.00584	CbGeAlD
Celecoxib—CA4—endocrine gland—brain cancer	0.00035	0.00565	CbGeAlD
Celecoxib—CA4—head—brain cancer	0.000346	0.00558	CbGeAlD
Celecoxib—ABCC4—central nervous system—brain cancer	0.000343	0.00554	CbGeAlD
Celecoxib—PTGS2—telencephalon—brain cancer	0.00034	0.00548	CbGeAlD
Celecoxib—CA2—midbrain—brain cancer	0.000331	0.00533	CbGeAlD
Celecoxib—CYP2D6—brainstem—brain cancer	0.000329	0.00531	CbGeAlD
Celecoxib—CA2—spinal cord—brain cancer	0.000323	0.0052	CbGeAlD
Celecoxib—CA4—central nervous system—brain cancer	0.000316	0.00509	CbGeAlD
Celecoxib—CA4—cerebellum—brain cancer	0.000309	0.00498	CbGeAlD
Celecoxib—CYP2D6—telencephalon—brain cancer	0.000292	0.00472	CbGeAlD
Celecoxib—CA2—endocrine gland—brain cancer	0.00029	0.00468	CbGeAlD
Celecoxib—CA2—head—brain cancer	0.000287	0.00463	CbGeAlD
Celecoxib—ALB—brain—brain cancer	0.000282	0.00454	CbGeAlD
Celecoxib—Hyperhidrosis—Procarbazine—brain cancer	0.000278	0.00195	CcSEcCtD
Celecoxib—Alopecia—Hydroxyurea—brain cancer	0.000277	0.00194	CcSEcCtD
Celecoxib—Neuropathy peripheral—Carmustine—brain cancer	0.000277	0.00194	CcSEcCtD
Celecoxib—PTGS2—pituitary gland—brain cancer	0.000277	0.00446	CbGeAlD
Celecoxib—Hyperglycaemia—Temozolomide—brain cancer	0.000276	0.00193	CcSEcCtD
Celecoxib—Stomatitis—Carmustine—brain cancer	0.000275	0.00193	CcSEcCtD
Celecoxib—Urinary tract infection—Carmustine—brain cancer	0.000275	0.00192	CcSEcCtD
Celecoxib—Pneumonia—Temozolomide—brain cancer	0.000275	0.00192	CcSEcCtD
Celecoxib—Anorexia—Procarbazine—brain cancer	0.000274	0.00192	CcSEcCtD
Celecoxib—Infestation NOS—Temozolomide—brain cancer	0.000273	0.00191	CcSEcCtD
Celecoxib—Infestation—Temozolomide—brain cancer	0.000273	0.00191	CcSEcCtD
Celecoxib—ABCC4—brain—brain cancer	0.000273	0.0044	CbGeAlD
Celecoxib—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000271	0.0019	CcSEcCtD
Celecoxib—Nausea—Lomustine—brain cancer	0.000269	0.00189	CcSEcCtD
Celecoxib—Neuropathy peripheral—Temozolomide—brain cancer	0.000268	0.00187	CcSEcCtD
Celecoxib—PTGS2—medulla oblongata—brain cancer	0.000267	0.00431	CbGeAlD
Celecoxib—Stomatitis—Temozolomide—brain cancer	0.000266	0.00186	CcSEcCtD
Celecoxib—Urinary tract infection—Temozolomide—brain cancer	0.000265	0.00186	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000262	0.00184	CcSEcCtD
Celecoxib—CA2—central nervous system—brain cancer	0.000262	0.00422	CbGeAlD
Celecoxib—Insomnia—Procarbazine—brain cancer	0.00026	0.00182	CcSEcCtD
Celecoxib—Paraesthesia—Procarbazine—brain cancer	0.000259	0.00181	CcSEcCtD
Celecoxib—Hepatobiliary disease—Temozolomide—brain cancer	0.000258	0.00181	CcSEcCtD
Celecoxib—Sinusitis—Temozolomide—brain cancer	0.000256	0.00179	CcSEcCtD
Celecoxib—Somnolence—Procarbazine—brain cancer	0.000256	0.00179	CcSEcCtD
Celecoxib—CA2—cerebellum—brain cancer	0.000256	0.00413	CbGeAlD
Celecoxib—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000255	0.00179	CcSEcCtD
Celecoxib—Haemoglobin—Carmustine—brain cancer	0.000255	0.00179	CcSEcCtD
Celecoxib—Haemorrhage—Carmustine—brain cancer	0.000254	0.00178	CcSEcCtD
Celecoxib—Anaemia—Hydroxyurea—brain cancer	0.000252	0.00177	CcSEcCtD
Celecoxib—Hallucination—Carmustine—brain cancer	0.000252	0.00177	CcSEcCtD
Celecoxib—Hypoaesthesia—Carmustine—brain cancer	0.000252	0.00177	CcSEcCtD
Celecoxib—CA4—brain—brain cancer	0.000251	0.00404	CbGeAlD
Celecoxib—Decreased appetite—Procarbazine—brain cancer	0.00025	0.00175	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Etoposide—brain cancer	0.00025	0.00175	CcSEcCtD
Celecoxib—Oedema peripheral—Carmustine—brain cancer	0.00025	0.00175	CcSEcCtD
Celecoxib—Connective tissue disorder—Carmustine—brain cancer	0.000249	0.00175	CcSEcCtD
Celecoxib—Fatigue—Procarbazine—brain cancer	0.000248	0.00174	CcSEcCtD
Celecoxib—Haemoglobin—Temozolomide—brain cancer	0.000246	0.00172	CcSEcCtD
Celecoxib—Constipation—Procarbazine—brain cancer	0.000246	0.00172	CcSEcCtD
Celecoxib—CYP2C9—endocrine gland—brain cancer	0.000246	0.00396	CbGeAlD
Celecoxib—Hepatitis—Temozolomide—brain cancer	0.000245	0.00172	CcSEcCtD
Celecoxib—Haemorrhage—Temozolomide—brain cancer	0.000245	0.00172	CcSEcCtD
Celecoxib—Dysphagia—Etoposide—brain cancer	0.000245	0.00172	CcSEcCtD
Celecoxib—Leukopenia—Hydroxyurea—brain cancer	0.000244	0.00171	CcSEcCtD
Celecoxib—PTGS2—midbrain—brain cancer	0.000244	0.00394	CbGeAlD
Celecoxib—Hypoaesthesia—Temozolomide—brain cancer	0.000244	0.00171	CcSEcCtD
Celecoxib—Hallucination—Temozolomide—brain cancer	0.000244	0.00171	CcSEcCtD
Celecoxib—Pharyngitis—Temozolomide—brain cancer	0.000243	0.0017	CcSEcCtD
Celecoxib—Urinary tract disorder—Temozolomide—brain cancer	0.000242	0.00169	CcSEcCtD
Celecoxib—Oedema peripheral—Temozolomide—brain cancer	0.000241	0.00169	CcSEcCtD
Celecoxib—Bronchospasm—Etoposide—brain cancer	0.000241	0.00169	CcSEcCtD
Celecoxib—Connective tissue disorder—Temozolomide—brain cancer	0.000241	0.00169	CcSEcCtD
Celecoxib—Urethral disorder—Temozolomide—brain cancer	0.00024	0.00168	CcSEcCtD
Celecoxib—Sweating increased—Etoposide—brain cancer	0.000239	0.00167	CcSEcCtD
Celecoxib—PTGS2—spinal cord—brain cancer	0.000238	0.00384	CbGeAlD
Celecoxib—Feeling abnormal—Procarbazine—brain cancer	0.000237	0.00166	CcSEcCtD
Celecoxib—Eye disorder—Carmustine—brain cancer	0.000237	0.00166	CcSEcCtD
Celecoxib—Gastrointestinal pain—Procarbazine—brain cancer	0.000235	0.00165	CcSEcCtD
Celecoxib—Flushing—Carmustine—brain cancer	0.000235	0.00165	CcSEcCtD
Celecoxib—Pancytopenia—Etoposide—brain cancer	0.000233	0.00163	CcSEcCtD
Celecoxib—Erythema multiforme—Temozolomide—brain cancer	0.000232	0.00162	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000231	0.00162	CcSEcCtD
Celecoxib—Eye disorder—Temozolomide—brain cancer	0.000229	0.0016	CcSEcCtD
Celecoxib—Urticaria—Procarbazine—brain cancer	0.000229	0.0016	CcSEcCtD
Celecoxib—Tinnitus—Temozolomide—brain cancer	0.000228	0.0016	CcSEcCtD
Celecoxib—Abdominal pain—Procarbazine—brain cancer	0.000228	0.00159	CcSEcCtD
Celecoxib—Body temperature increased—Procarbazine—brain cancer	0.000228	0.00159	CcSEcCtD
Celecoxib—Cardiac disorder—Temozolomide—brain cancer	0.000227	0.00159	CcSEcCtD
Celecoxib—Flushing—Temozolomide—brain cancer	0.000227	0.00159	CcSEcCtD
Celecoxib—Arrhythmia—Carmustine—brain cancer	0.000227	0.00159	CcSEcCtD
Celecoxib—Alopecia—Carmustine—brain cancer	0.000224	0.00157	CcSEcCtD
Celecoxib—Oedema—Hydroxyurea—brain cancer	0.000223	0.00156	CcSEcCtD
Celecoxib—Angiopathy—Temozolomide—brain cancer	0.000222	0.00156	CcSEcCtD
Celecoxib—Mental disorder—Carmustine—brain cancer	0.000222	0.00156	CcSEcCtD
Celecoxib—Infection—Hydroxyurea—brain cancer	0.000221	0.00155	CcSEcCtD
Celecoxib—Immune system disorder—Temozolomide—brain cancer	0.000221	0.00155	CcSEcCtD
Celecoxib—Mediastinal disorder—Temozolomide—brain cancer	0.000221	0.00155	CcSEcCtD
Celecoxib—Pneumonia—Etoposide—brain cancer	0.00022	0.00154	CcSEcCtD
Celecoxib—Nervous system disorder—Hydroxyurea—brain cancer	0.000219	0.00153	CcSEcCtD
Celecoxib—Infestation—Etoposide—brain cancer	0.000218	0.00153	CcSEcCtD
Celecoxib—Infestation NOS—Etoposide—brain cancer	0.000218	0.00153	CcSEcCtD
Celecoxib—Thrombocytopenia—Hydroxyurea—brain cancer	0.000218	0.00153	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000217	0.00152	CcSEcCtD
Celecoxib—Alopecia—Temozolomide—brain cancer	0.000217	0.00152	CcSEcCtD
Celecoxib—Skin disorder—Hydroxyurea—brain cancer	0.000216	0.00152	CcSEcCtD
Celecoxib—Acute coronary syndrome—Etoposide—brain cancer	0.000215	0.00151	CcSEcCtD
Celecoxib—Mental disorder—Temozolomide—brain cancer	0.000215	0.0015	CcSEcCtD
Celecoxib—PTGS2—endocrine gland—brain cancer	0.000214	0.00346	CbGeAlD
Celecoxib—Neuropathy peripheral—Etoposide—brain cancer	0.000214	0.0015	CcSEcCtD
Celecoxib—Myocardial infarction—Etoposide—brain cancer	0.000214	0.0015	CcSEcCtD
Celecoxib—Back pain—Carmustine—brain cancer	0.000214	0.0015	CcSEcCtD
Celecoxib—Jaundice—Etoposide—brain cancer	0.000213	0.00149	CcSEcCtD
Celecoxib—Stomatitis—Etoposide—brain cancer	0.000213	0.00149	CcSEcCtD
Celecoxib—Anorexia—Hydroxyurea—brain cancer	0.000212	0.00149	CcSEcCtD
Celecoxib—Hypersensitivity—Procarbazine—brain cancer	0.000212	0.00149	CcSEcCtD
Celecoxib—PTGS2—head—brain cancer	0.000212	0.00341	CbGeAlD
Celecoxib—Dysgeusia—Temozolomide—brain cancer	0.000209	0.00146	CcSEcCtD
Celecoxib—Vision blurred—Carmustine—brain cancer	0.000208	0.00146	CcSEcCtD
Celecoxib—CA2—brain—brain cancer	0.000208	0.00335	CbGeAlD
Celecoxib—Asthenia—Procarbazine—brain cancer	0.000207	0.00145	CcSEcCtD
Celecoxib—Hepatobiliary disease—Etoposide—brain cancer	0.000207	0.00145	CcSEcCtD
Celecoxib—Back pain—Temozolomide—brain cancer	0.000206	0.00145	CcSEcCtD
Celecoxib—Anaemia—Carmustine—brain cancer	0.000204	0.00143	CcSEcCtD
Celecoxib—Agranulocytosis—Etoposide—brain cancer	0.000204	0.00143	CcSEcCtD
Celecoxib—Pruritus—Procarbazine—brain cancer	0.000204	0.00143	CcSEcCtD
Celecoxib—Vision blurred—Temozolomide—brain cancer	0.000201	0.00141	CcSEcCtD
Celecoxib—Dyspnoea—Hydroxyurea—brain cancer	0.000199	0.00139	CcSEcCtD
Celecoxib—Somnolence—Hydroxyurea—brain cancer	0.000198	0.00139	CcSEcCtD
Celecoxib—Leukopenia—Carmustine—brain cancer	0.000198	0.00138	CcSEcCtD
Celecoxib—Anaemia—Temozolomide—brain cancer	0.000197	0.00138	CcSEcCtD
Celecoxib—Diarrhoea—Procarbazine—brain cancer	0.000197	0.00138	CcSEcCtD
Celecoxib—Dyspepsia—Hydroxyurea—brain cancer	0.000196	0.00137	CcSEcCtD
Celecoxib—Hypoaesthesia—Etoposide—brain cancer	0.000195	0.00137	CcSEcCtD
Celecoxib—Angioedema—Temozolomide—brain cancer	0.000195	0.00137	CcSEcCtD
Celecoxib—Decreased appetite—Hydroxyurea—brain cancer	0.000194	0.00136	CcSEcCtD
Celecoxib—Urinary tract disorder—Etoposide—brain cancer	0.000194	0.00136	CcSEcCtD
Celecoxib—PTGS2—central nervous system—brain cancer	0.000193	0.00312	CbGeAlD
Celecoxib—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000192	0.00135	CcSEcCtD
Celecoxib—Urethral disorder—Etoposide—brain cancer	0.000192	0.00135	CcSEcCtD
Celecoxib—Fatigue—Hydroxyurea—brain cancer	0.000192	0.00135	CcSEcCtD
Celecoxib—Vertigo—Temozolomide—brain cancer	0.000192	0.00134	CcSEcCtD
Celecoxib—Leukopenia—Temozolomide—brain cancer	0.000191	0.00134	CcSEcCtD
Celecoxib—Hypertension—Carmustine—brain cancer	0.000191	0.00133	CcSEcCtD
Celecoxib—Constipation—Hydroxyurea—brain cancer	0.000191	0.00133	CcSEcCtD
Celecoxib—Dizziness—Procarbazine—brain cancer	0.00019	0.00133	CcSEcCtD
Celecoxib—PTGS2—cerebellum—brain cancer	0.000189	0.00305	CbGeAlD
Celecoxib—Palpitations—Temozolomide—brain cancer	0.000188	0.00132	CcSEcCtD
Celecoxib—Myalgia—Carmustine—brain cancer	0.000188	0.00132	CcSEcCtD
Celecoxib—Chest pain—Carmustine—brain cancer	0.000188	0.00132	CcSEcCtD
Celecoxib—CYP3A4—endocrine gland—brain cancer	0.000187	0.00302	CbGeAlD
Celecoxib—Anxiety—Carmustine—brain cancer	0.000187	0.00131	CcSEcCtD
Celecoxib—Cough—Temozolomide—brain cancer	0.000186	0.0013	CcSEcCtD
Celecoxib—Erythema multiforme—Etoposide—brain cancer	0.000185	0.0013	CcSEcCtD
Celecoxib—CYP2D6—endocrine gland—brain cancer	0.000184	0.00297	CbGeAlD
Celecoxib—Hypertension—Temozolomide—brain cancer	0.000184	0.00129	CcSEcCtD
Celecoxib—Feeling abnormal—Hydroxyurea—brain cancer	0.000184	0.00129	CcSEcCtD
Celecoxib—Eye disorder—Etoposide—brain cancer	0.000183	0.00128	CcSEcCtD
Celecoxib—Vomiting—Procarbazine—brain cancer	0.000183	0.00128	CcSEcCtD
Celecoxib—CYP2D6—head—brain cancer	0.000182	0.00294	CbGeAlD
Celecoxib—Flushing—Etoposide—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Cardiac disorder—Etoposide—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Confusional state—Carmustine—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Arthralgia—Temozolomide—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Myalgia—Temozolomide—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Rash—Procarbazine—brain cancer	0.000182	0.00127	CcSEcCtD
Celecoxib—Dermatitis—Procarbazine—brain cancer	0.000181	0.00127	CcSEcCtD
Celecoxib—Anxiety—Temozolomide—brain cancer	0.000181	0.00127	CcSEcCtD
Celecoxib—Headache—Procarbazine—brain cancer	0.00018	0.00126	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00018	0.00126	CcSEcCtD
Celecoxib—Oedema—Carmustine—brain cancer	0.00018	0.00126	CcSEcCtD
Celecoxib—Infection—Carmustine—brain cancer	0.000179	0.00125	CcSEcCtD
Celecoxib—Angiopathy—Etoposide—brain cancer	0.000178	0.00125	CcSEcCtD
Celecoxib—Dry mouth—Temozolomide—brain cancer	0.000178	0.00124	CcSEcCtD
Celecoxib—Immune system disorder—Etoposide—brain cancer	0.000177	0.00124	CcSEcCtD
Celecoxib—Mediastinal disorder—Etoposide—brain cancer	0.000177	0.00124	CcSEcCtD
Celecoxib—Thrombocytopenia—Carmustine—brain cancer	0.000176	0.00124	CcSEcCtD
Celecoxib—Body temperature increased—Hydroxyurea—brain cancer	0.000176	0.00123	CcSEcCtD
Celecoxib—Tachycardia—Carmustine—brain cancer	0.000176	0.00123	CcSEcCtD
Celecoxib—Confusional state—Temozolomide—brain cancer	0.000176	0.00123	CcSEcCtD
Celecoxib—Oedema—Temozolomide—brain cancer	0.000174	0.00122	CcSEcCtD
Celecoxib—Anaphylactic shock—Temozolomide—brain cancer	0.000174	0.00122	CcSEcCtD
Celecoxib—Alopecia—Etoposide—brain cancer	0.000173	0.00121	CcSEcCtD
Celecoxib—Infection—Temozolomide—brain cancer	0.000173	0.00121	CcSEcCtD
Celecoxib—Anorexia—Carmustine—brain cancer	0.000172	0.0012	CcSEcCtD
Celecoxib—Nausea—Procarbazine—brain cancer	0.000171	0.0012	CcSEcCtD
Celecoxib—Nervous system disorder—Temozolomide—brain cancer	0.000171	0.0012	CcSEcCtD
Celecoxib—Thrombocytopenia—Temozolomide—brain cancer	0.00017	0.00119	CcSEcCtD
Celecoxib—Skin disorder—Temozolomide—brain cancer	0.000169	0.00118	CcSEcCtD
Celecoxib—CYP3A4—central nervous system—brain cancer	0.000169	0.00272	CbGeAlD
Celecoxib—Hyperhidrosis—Temozolomide—brain cancer	0.000168	0.00118	CcSEcCtD
Celecoxib—Dysgeusia—Etoposide—brain cancer	0.000167	0.00117	CcSEcCtD
Celecoxib—CYP2D6—central nervous system—brain cancer	0.000166	0.00268	CbGeAlD
Celecoxib—Anorexia—Temozolomide—brain cancer	0.000166	0.00116	CcSEcCtD
Celecoxib—Back pain—Etoposide—brain cancer	0.000165	0.00116	CcSEcCtD
Celecoxib—Hypersensitivity—Hydroxyurea—brain cancer	0.000164	0.00115	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Carmustine—brain cancer	0.000164	0.00115	CcSEcCtD
Celecoxib—Muscle spasms—Etoposide—brain cancer	0.000164	0.00115	CcSEcCtD
Celecoxib—Insomnia—Carmustine—brain cancer	0.000163	0.00114	CcSEcCtD
Celecoxib—CYP2D6—cerebellum—brain cancer	0.000162	0.00262	CbGeAlD
Celecoxib—Paraesthesia—Carmustine—brain cancer	0.000162	0.00113	CcSEcCtD
Celecoxib—Dyspnoea—Carmustine—brain cancer	0.000161	0.00112	CcSEcCtD
Celecoxib—Somnolence—Carmustine—brain cancer	0.00016	0.00112	CcSEcCtD
Celecoxib—Asthenia—Hydroxyurea—brain cancer	0.00016	0.00112	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000159	0.00111	CcSEcCtD
Celecoxib—Anaemia—Etoposide—brain cancer	0.000158	0.0011	CcSEcCtD
Celecoxib—Insomnia—Temozolomide—brain cancer	0.000157	0.0011	CcSEcCtD
Celecoxib—Decreased appetite—Carmustine—brain cancer	0.000157	0.0011	CcSEcCtD
Celecoxib—Paraesthesia—Temozolomide—brain cancer	0.000156	0.00109	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Carmustine—brain cancer	0.000156	0.00109	CcSEcCtD
Celecoxib—Dyspnoea—Temozolomide—brain cancer	0.000155	0.00109	CcSEcCtD
Celecoxib—Somnolence—Temozolomide—brain cancer	0.000155	0.00108	CcSEcCtD
Celecoxib—Constipation—Carmustine—brain cancer	0.000154	0.00108	CcSEcCtD
Celecoxib—PTGS2—brain—brain cancer	0.000153	0.00247	CbGeAlD
Celecoxib—Vertigo—Etoposide—brain cancer	0.000153	0.00107	CcSEcCtD
Celecoxib—Dyspepsia—Temozolomide—brain cancer	0.000153	0.00107	CcSEcCtD
Celecoxib—Leukopenia—Etoposide—brain cancer	0.000153	0.00107	CcSEcCtD
Celecoxib—Diarrhoea—Hydroxyurea—brain cancer	0.000152	0.00107	CcSEcCtD
Celecoxib—Decreased appetite—Temozolomide—brain cancer	0.000151	0.00106	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Temozolomide—brain cancer	0.00015	0.00105	CcSEcCtD
Celecoxib—Fatigue—Temozolomide—brain cancer	0.00015	0.00105	CcSEcCtD
Celecoxib—Loss of consciousness—Etoposide—brain cancer	0.00015	0.00105	CcSEcCtD
Celecoxib—Cough—Etoposide—brain cancer	0.000149	0.00104	CcSEcCtD
Celecoxib—Constipation—Temozolomide—brain cancer	0.000149	0.00104	CcSEcCtD
Celecoxib—Feeling abnormal—Carmustine—brain cancer	0.000148	0.00104	CcSEcCtD
Celecoxib—Hypertension—Etoposide—brain cancer	0.000147	0.00103	CcSEcCtD
Celecoxib—Dizziness—Hydroxyurea—brain cancer	0.000147	0.00103	CcSEcCtD
Celecoxib—Gastrointestinal pain—Carmustine—brain cancer	0.000147	0.00103	CcSEcCtD
Celecoxib—Chest pain—Etoposide—brain cancer	0.000145	0.00102	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000144	0.00101	CcSEcCtD
Celecoxib—Feeling abnormal—Temozolomide—brain cancer	0.000143	0.001	CcSEcCtD
Celecoxib—Body temperature increased—Carmustine—brain cancer	0.000142	0.000997	CcSEcCtD
Celecoxib—Abdominal pain—Carmustine—brain cancer	0.000142	0.000997	CcSEcCtD
Celecoxib—Gastrointestinal pain—Temozolomide—brain cancer	0.000142	0.000997	CcSEcCtD
Celecoxib—Vomiting—Hydroxyurea—brain cancer	0.000142	0.000992	CcSEcCtD
Celecoxib—Rash—Hydroxyurea—brain cancer	0.00014	0.000984	CcSEcCtD
Celecoxib—Confusional state—Etoposide—brain cancer	0.00014	0.000984	CcSEcCtD
Celecoxib—Dermatitis—Hydroxyurea—brain cancer	0.00014	0.000983	CcSEcCtD
Celecoxib—Headache—Hydroxyurea—brain cancer	0.00014	0.000978	CcSEcCtD
Celecoxib—Anaphylactic shock—Etoposide—brain cancer	0.000139	0.000976	CcSEcCtD
Celecoxib—Infection—Etoposide—brain cancer	0.000138	0.000969	CcSEcCtD
Celecoxib—Urticaria—Temozolomide—brain cancer	0.000138	0.000969	CcSEcCtD
Celecoxib—Abdominal pain—Temozolomide—brain cancer	0.000138	0.000964	CcSEcCtD
Celecoxib—Body temperature increased—Temozolomide—brain cancer	0.000138	0.000964	CcSEcCtD
Celecoxib—Thrombocytopenia—Etoposide—brain cancer	0.000136	0.000955	CcSEcCtD
Celecoxib—Tachycardia—Etoposide—brain cancer	0.000136	0.000952	CcSEcCtD
Celecoxib—Skin disorder—Etoposide—brain cancer	0.000135	0.000948	CcSEcCtD
Celecoxib—Hyperhidrosis—Etoposide—brain cancer	0.000135	0.000943	CcSEcCtD
Celecoxib—Anorexia—Etoposide—brain cancer	0.000133	0.00093	CcSEcCtD
Celecoxib—Hypersensitivity—Carmustine—brain cancer	0.000133	0.00093	CcSEcCtD
Celecoxib—Nausea—Hydroxyurea—brain cancer	0.000132	0.000927	CcSEcCtD
Celecoxib—CYP2D6—brain—brain cancer	0.000132	0.00213	CbGeAlD
Celecoxib—Asthenia—Carmustine—brain cancer	0.000129	0.000905	CcSEcCtD
Celecoxib—Hypersensitivity—Temozolomide—brain cancer	0.000128	0.000898	CcSEcCtD
Celecoxib—Paraesthesia—Etoposide—brain cancer	0.000125	0.000876	CcSEcCtD
Celecoxib—Asthenia—Temozolomide—brain cancer	0.000125	0.000875	CcSEcCtD
Celecoxib—Dyspnoea—Etoposide—brain cancer	0.000124	0.00087	CcSEcCtD
Celecoxib—Somnolence—Etoposide—brain cancer	0.000124	0.000867	CcSEcCtD
Celecoxib—Diarrhoea—Carmustine—brain cancer	0.000123	0.000863	CcSEcCtD
Celecoxib—Pruritus—Temozolomide—brain cancer	0.000123	0.000863	CcSEcCtD
Celecoxib—Decreased appetite—Etoposide—brain cancer	0.000121	0.000848	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Etoposide—brain cancer	0.00012	0.000842	CcSEcCtD
Celecoxib—Fatigue—Etoposide—brain cancer	0.00012	0.000841	CcSEcCtD
Celecoxib—Dizziness—Carmustine—brain cancer	0.000119	0.000834	CcSEcCtD
Celecoxib—Constipation—Etoposide—brain cancer	0.000119	0.000834	CcSEcCtD
Celecoxib—Diarrhoea—Temozolomide—brain cancer	0.000119	0.000834	CcSEcCtD
Celecoxib—Dizziness—Temozolomide—brain cancer	0.000115	0.000806	CcSEcCtD
Celecoxib—Feeling abnormal—Etoposide—brain cancer	0.000115	0.000804	CcSEcCtD
Celecoxib—Vomiting—Carmustine—brain cancer	0.000115	0.000802	CcSEcCtD
Celecoxib—Gastrointestinal pain—Etoposide—brain cancer	0.000114	0.000798	CcSEcCtD
Celecoxib—Rash—Carmustine—brain cancer	0.000114	0.000796	CcSEcCtD
Celecoxib—Dermatitis—Carmustine—brain cancer	0.000113	0.000795	CcSEcCtD
Celecoxib—Headache—Carmustine—brain cancer	0.000113	0.00079	CcSEcCtD
Celecoxib—Vomiting—Temozolomide—brain cancer	0.000111	0.000775	CcSEcCtD
Celecoxib—Urticaria—Etoposide—brain cancer	0.000111	0.000775	CcSEcCtD
Celecoxib—Body temperature increased—Etoposide—brain cancer	0.00011	0.000771	CcSEcCtD
Celecoxib—Abdominal pain—Etoposide—brain cancer	0.00011	0.000771	CcSEcCtD
Celecoxib—Rash—Temozolomide—brain cancer	0.00011	0.000769	CcSEcCtD
Celecoxib—Dermatitis—Temozolomide—brain cancer	0.00011	0.000768	CcSEcCtD
Celecoxib—Headache—Temozolomide—brain cancer	0.000109	0.000764	CcSEcCtD
Celecoxib—Nausea—Carmustine—brain cancer	0.000107	0.000749	CcSEcCtD
Celecoxib—Nausea—Temozolomide—brain cancer	0.000103	0.000724	CcSEcCtD
Celecoxib—Hypersensitivity—Etoposide—brain cancer	0.000103	0.000719	CcSEcCtD
Celecoxib—Asthenia—Etoposide—brain cancer	9.99e-05	0.0007	CcSEcCtD
Celecoxib—Pruritus—Etoposide—brain cancer	9.86e-05	0.00069	CcSEcCtD
Celecoxib—Diarrhoea—Etoposide—brain cancer	9.53e-05	0.000668	CcSEcCtD
Celecoxib—Dizziness—Etoposide—brain cancer	9.21e-05	0.000645	CcSEcCtD
Celecoxib—Vomiting—Etoposide—brain cancer	8.86e-05	0.00062	CcSEcCtD
Celecoxib—Rash—Etoposide—brain cancer	8.78e-05	0.000615	CcSEcCtD
Celecoxib—Dermatitis—Etoposide—brain cancer	8.77e-05	0.000615	CcSEcCtD
Celecoxib—Headache—Etoposide—brain cancer	8.73e-05	0.000611	CcSEcCtD
Celecoxib—Nausea—Etoposide—brain cancer	8.27e-05	0.00058	CcSEcCtD
Celecoxib—ALB—Hemostasis—BSG—brain cancer	4.45e-05	0.000415	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—STAT3—brain cancer	4.44e-05	0.000414	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—RELA—brain cancer	4.4e-05	0.00041	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—EGFR—brain cancer	4.39e-05	0.000409	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—STAT3—brain cancer	4.35e-05	0.000405	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—MYC—brain cancer	4.33e-05	0.000404	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.31e-05	0.000402	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	4.28e-05	0.000399	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—brain cancer	4.27e-05	0.000398	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—VAV1—brain cancer	4.27e-05	0.000398	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VAV1—brain cancer	4.24e-05	0.000396	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VAV1—brain cancer	4.23e-05	0.000394	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	4.19e-05	0.000391	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.02e-05	0.000375	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.98e-05	0.000371	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.98e-05	0.000371	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—MYC—brain cancer	3.97e-05	0.00037	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—brain cancer	3.96e-05	0.000369	CbGpPWpGaD
Celecoxib—PDPK1—Disease—VAV1—brain cancer	3.94e-05	0.000367	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ENO2—brain cancer	3.94e-05	0.000367	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL2—brain cancer	3.87e-05	0.000361	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—brain cancer	3.87e-05	0.00036	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTCH2—brain cancer	3.86e-05	0.000359	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SHH—brain cancer	3.82e-05	0.000356	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—VAV1—brain cancer	3.81e-05	0.000355	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CCND1—brain cancer	3.78e-05	0.000352	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	3.74e-05	0.000349	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HES5—brain cancer	3.73e-05	0.000348	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HES1—brain cancer	3.71e-05	0.000346	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TRPC6—brain cancer	3.69e-05	0.000343	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CDKN2A—brain cancer	3.67e-05	0.000342	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—brain cancer	3.67e-05	0.000342	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—IL2—brain cancer	3.64e-05	0.000339	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—RELA—brain cancer	3.64e-05	0.000339	CbGpPWpGaD
Celecoxib—ALB—Platelet degranulation—VEGFA—brain cancer	3.63e-05	0.000339	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STRADA—brain cancer	3.63e-05	0.000338	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SMO—brain cancer	3.62e-05	0.000338	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTCH1—brain cancer	3.62e-05	0.000338	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—ERBB2—brain cancer	3.62e-05	0.000337	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—brain cancer	3.6e-05	0.000335	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—MYC—brain cancer	3.57e-05	0.000333	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.56e-05	0.000332	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TP53—brain cancer	3.56e-05	0.000332	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—STAT3—brain cancer	3.54e-05	0.00033	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—RELA—brain cancer	3.53e-05	0.000329	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.5e-05	0.000327	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PDGFRA—brain cancer	3.5e-05	0.000326	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—EGFR—brain cancer	3.49e-05	0.000326	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—RELA—brain cancer	3.49e-05	0.000326	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.49e-05	0.000325	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—ERBB2—brain cancer	3.47e-05	0.000324	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	3.46e-05	0.000323	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HES5—brain cancer	3.41e-05	0.000317	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HES1—brain cancer	3.39e-05	0.000316	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—TP53—brain cancer	3.39e-05	0.000316	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PIK3CG—brain cancer	3.33e-05	0.00031	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—RELA—brain cancer	3.31e-05	0.000309	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—ERBB2—brain cancer	3.29e-05	0.000307	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—PIK3CG—brain cancer	3.27e-05	0.000305	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	3.27e-05	0.000304	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PIK3CG—brain cancer	3.24e-05	0.000302	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PIK3CG—brain cancer	3.24e-05	0.000302	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PDGFRA—brain cancer	3.23e-05	0.000301	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.22e-05	0.0003	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TP53—brain cancer	3.2e-05	0.000298	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CTNNB1—brain cancer	3.16e-05	0.000295	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.15e-05	0.000294	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PDGFRA—brain cancer	3.12e-05	0.000291	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—brain cancer	3.12e-05	0.000291	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—VEGFA—brain cancer	3.09e-05	0.000288	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IRS2—brain cancer	3.07e-05	0.000286	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—PIK3CG—brain cancer	3.07e-05	0.000286	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—MYC—brain cancer	3.03e-05	0.000282	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ABR—brain cancer	3.03e-05	0.000282	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PIK3CG—brain cancer	3.03e-05	0.000282	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	2.97e-05	0.000277	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PIK3CG—brain cancer	2.97e-05	0.000277	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—EGFR—brain cancer	2.96e-05	0.000276	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TP53—brain cancer	2.93e-05	0.000273	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GLI2—brain cancer	2.92e-05	0.000272	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TRPC6—brain cancer	2.92e-05	0.000272	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SKP2—brain cancer	2.91e-05	0.000271	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CDK4—brain cancer	2.91e-05	0.000271	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.91e-05	0.000271	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOTCH2—brain cancer	2.9e-05	0.00027	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.85e-05	0.000266	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IRS2—brain cancer	2.84e-05	0.000264	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PIK3CG—brain cancer	2.8e-05	0.000261	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VAV1—brain cancer	2.76e-05	0.000257	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GLI1—brain cancer	2.75e-05	0.000256	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IRS2—brain cancer	2.74e-05	0.000255	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—DNMT1—brain cancer	2.72e-05	0.000254	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—VEGFA—brain cancer	2.7e-05	0.000252	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—TP53—brain cancer	2.7e-05	0.000252	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	2.7e-05	0.000251	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—PIK3CG—brain cancer	2.69e-05	0.00025	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—STAT3—brain cancer	2.68e-05	0.00025	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.65e-05	0.000247	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP2C9—brain cancer	2.63e-05	0.000245	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SUFU—brain cancer	2.6e-05	0.000243	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.57e-05	0.000239	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.54e-05	0.000237	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	2.53e-05	0.000236	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GFAP—brain cancer	2.51e-05	0.000234	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—STAT3—brain cancer	2.51e-05	0.000234	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—brain cancer	2.51e-05	0.000234	CbGpPWpGaD
Celecoxib—PDPK1—Disease—APC—brain cancer	2.5e-05	0.000233	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TP53—brain cancer	2.49e-05	0.000232	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—ESR2—brain cancer	2.44e-05	0.000228	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—brain cancer	2.41e-05	0.000224	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HEY1—brain cancer	2.38e-05	0.000222	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HES1—brain cancer	2.38e-05	0.000221	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TP53—brain cancer	2.34e-05	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DLL1—brain cancer	2.34e-05	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NOTCH2—brain cancer	2.32e-05	0.000216	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—brain cancer	2.3e-05	0.000214	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IDH1—brain cancer	2.29e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—brain cancer	2.28e-05	0.000213	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PDGFRA—brain cancer	2.26e-05	0.000211	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.24e-05	0.000209	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PIK3CG—brain cancer	2.24e-05	0.000208	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—BSG—brain cancer	2.23e-05	0.000208	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—VAV1—brain cancer	2.22e-05	0.000207	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SPP1—brain cancer	2.2e-05	0.000205	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VAV1—brain cancer	2.19e-05	0.000204	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HEY1—brain cancer	2.17e-05	0.000203	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—brain cancer	2.16e-05	0.000201	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PIK3CG—brain cancer	2.14e-05	0.0002	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—RELA—brain cancer	2.14e-05	0.000199	CbGpPWpGaD
Celecoxib—PTGS2—Disease—DLL1—brain cancer	2.13e-05	0.000199	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—ERBB2—brain cancer	2.13e-05	0.000198	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP2C9—brain cancer	2.12e-05	0.000198	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—RELA—brain cancer	2.12e-05	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ERBB2—brain cancer	2.11e-05	0.000196	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—brain cancer	2.09e-05	0.000195	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.06e-05	0.000192	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—TP53—brain cancer	2.04e-05	0.00019	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.01e-05	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SHH—brain cancer	1.99e-05	0.000185	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IRS2—brain cancer	1.99e-05	0.000185	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SIRT1—brain cancer	1.97e-05	0.000183	CbGpPWpGaD
Celecoxib—PDPK1—Disease—ERBB2—brain cancer	1.94e-05	0.000181	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—IDH1—brain cancer	1.92e-05	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TRPC6—brain cancer	1.92e-05	0.000178	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—brain cancer	1.91e-05	0.000178	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.9e-05	0.000177	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—brain cancer	1.89e-05	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RELA—brain cancer	1.89e-05	0.000176	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTCH1—brain cancer	1.88e-05	0.000175	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMO—brain cancer	1.88e-05	0.000175	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—ERBB2—brain cancer	1.88e-05	0.000175	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CTNNB1—brain cancer	1.86e-05	0.000173	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CTNNB1—brain cancer	1.84e-05	0.000172	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—VEGFA—brain cancer	1.84e-05	0.000171	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PDGFRA—brain cancer	1.82e-05	0.000169	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SHH—brain cancer	1.81e-05	0.000169	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ENO2—brain cancer	1.81e-05	0.000169	CbGpPWpGaD
Celecoxib—ALB—Metabolism—BSG—brain cancer	1.81e-05	0.000168	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PIK3CG—brain cancer	1.81e-05	0.000168	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP2C9—brain cancer	1.75e-05	0.000163	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PIK3CG—brain cancer	1.75e-05	0.000163	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—APC—brain cancer	1.75e-05	0.000163	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CTNNB1—brain cancer	1.7e-05	0.000159	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.69e-05	0.000158	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CTNNB1—brain cancer	1.64e-05	0.000153	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—VEGFA—brain cancer	1.64e-05	0.000153	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—STAT3—brain cancer	1.62e-05	0.000151	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.61e-05	0.00015	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—VEGFA—brain cancer	1.61e-05	0.00015	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—STAT3—brain cancer	1.61e-05	0.00015	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—brain cancer	1.6e-05	0.000149	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS2—brain cancer	1.6e-05	0.000149	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.56e-05	0.000146	CbGpPWpGaD
Celecoxib—ALB—Metabolism—IDH1—brain cancer	1.55e-05	0.000145	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ENO2—brain cancer	1.52e-05	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOTCH2—brain cancer	1.51e-05	0.00014	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BSG—brain cancer	1.49e-05	0.000139	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STAT3—brain cancer	1.48e-05	0.000138	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BSG—brain cancer	1.48e-05	0.000138	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—brain cancer	1.47e-05	0.000137	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—brain cancer	1.46e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VAV1—brain cancer	1.44e-05	0.000134	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CG—brain cancer	1.39e-05	0.000129	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TP53—brain cancer	1.39e-05	0.000129	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MYC—brain cancer	1.38e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RELA—brain cancer	1.37e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB2—brain cancer	1.36e-05	0.000127	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—brain cancer	1.35e-05	0.000126	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VAV1—brain cancer	1.31e-05	0.000122	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—brain cancer	1.3e-05	0.000121	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—IDH1—brain cancer	1.28e-05	0.00012	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—IDH1—brain cancer	1.27e-05	0.000118	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.26e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HES1—brain cancer	1.23e-05	0.000115	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—brain cancer	1.23e-05	0.000115	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ENO2—brain cancer	1.23e-05	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TP53—brain cancer	1.21e-05	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCND1—brain cancer	1.2e-05	0.000112	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CTNNB1—brain cancer	1.19e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDGFRA—brain cancer	1.18e-05	0.00011	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—brain cancer	1.14e-05	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HES1—brain cancer	1.13e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RELA—brain cancer	1.1e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB2—brain cancer	1.09e-05	0.000102	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PDGFRA—brain cancer	1.07e-05	9.99e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—brain cancer	1.05e-05	9.77e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—brain cancer	1.04e-05	9.68e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.04e-05	9.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS2—brain cancer	1.03e-05	9.61e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ENO2—brain cancer	1.01e-05	9.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ENO2—brain cancer	1e-05	9.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—brain cancer	9.92e-06	9.24e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—brain cancer	9.78e-06	9.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BSG—brain cancer	9.75e-06	9.09e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MYC—brain cancer	9.65e-06	8.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTNNB1—brain cancer	9.57e-06	8.92e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—brain cancer	9.44e-06	8.79e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS2—brain cancer	9.41e-06	8.77e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APC—brain cancer	9.11e-06	8.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CG—brain cancer	9.11e-06	8.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—IDH1—brain cancer	8.38e-06	7.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—brain cancer	8.35e-06	7.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APC—brain cancer	8.31e-06	7.75e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—brain cancer	8.31e-06	7.74e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TP53—brain cancer	7.92e-06	7.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MYC—brain cancer	7.71e-06	7.19e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—brain cancer	7.59e-06	7.07e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RELA—brain cancer	7.12e-06	6.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB2—brain cancer	7.08e-06	6.59e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CG—brain cancer	6.96e-06	6.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ENO2—brain cancer	6.63e-06	6.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB2—brain cancer	6.45e-06	6.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—brain cancer	6.41e-06	5.98e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TP53—brain cancer	6.28e-06	5.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCND1—brain cancer	6.25e-06	5.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CTNNB1—brain cancer	6.19e-06	5.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CTNNB1—brain cancer	5.65e-06	5.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CG—brain cancer	5.63e-06	5.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—brain cancer	5.45e-06	5.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—brain cancer	5.4e-06	5.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MYC—brain cancer	5.01e-06	4.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—brain cancer	4.92e-06	4.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—brain cancer	4.9e-06	4.57e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CG—brain cancer	4.65e-06	4.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CG—brain cancer	4.61e-06	4.3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MYC—brain cancer	4.57e-06	4.26e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—brain cancer	4.47e-06	4.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TP53—brain cancer	4.12e-06	3.84e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CG—brain cancer	3.04e-06	2.83e-05	CbGpPWpGaD
